2010 Annual Meeting | Cerebrovascular Disease

Date Sunday 04/11/10

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) Robert D. Brown, Jr., MD, MPH, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the latest recommendations and controversies regarding the evaluation and management of patients with all stroke types, including acute ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage; be able to initiate optimal secondary prevention strategies after ischemic stroke, including selection of the optimal antithrombotic agent using the most recently published data and appropriate aggressive risk factor management; be able to manage intracranial and extracranial large artery occlusive disease, selecting the best surgical or endovascular option; be able to optimally manage issues related to ischemic stroke in young adults, including patent foramen ovale and prothrombotic states; and understand key issues in the management of unruptured intracranial aneurysms.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
09:00 AM - 09:40 AM		Contemporary Management of Acute Ischemic Stroke Jeffrey L. Saver, MD, FAAN
09:40 AM - 09:55 AM		Questions and Answers Jeffrey L. Saver, MD, FAAN
09:55 AM - 10:35 AM		Ischemic Stroke in the Young Adult: Evaluation and Management Cathy A. Sila, MD, FAAN
10:35 AM - 10:45 AM		Questions and Answers Cathy A. Sila, MD, FAAN
10:45 AM - 11:00 AM		Break
11:00 AM - 11:35 AM		Management of Intracranial and Extracranial Large Artery Disease Thomas G. Brott, MD, FAAN
11:35 AM - 11:45 PM		Questions and Answers Thomas G. Brott, MD, FAAN
11:45 AM - 12:20 PM		Secondary Prevention After TIA or Ischemic Stroke: Using Available Data to Select the Optimal Antithrombotic Therapy Harold P. Adams, Jr., MD, FAAN
12:20 PM - 12:30 PM		Questions and Answers Harold P. Adams, Jr., MD, FAAN
12:30 PM - 01:30 PM		Lunch
01:30 PM - 02:10 PM		Secondary Prevention After TIA or Ischemic Stroke: Risk Factor Management Ralph L. Sacco, MD, MS, FAHA
02:10 PM - 02:20 PM		Questions and Answers Ralph L. Sacco, MD, MS, FAHA
02:20 PM - 02:55 PM		Contemporary Management of Intracerebral Hemorrhage Joseph P. Broderick, MD, FAAN
02:55 PM - 03:05 PM		Questions and Answers Joseph P. Broderick, MD, FAAN
03:05 PM - 03:40 PM		Contemporary Management of Subarachnoid Hemorrhage Alejandro A. Rabinstein, MD, FAAN
03:40 PM - 03:45 PM		Questions and Answers Alejandro A. Rabinstein, MD, FAAN
03:45 PM - 04:00 PM		Break
04:00 PM - 04:35 PM		Key Issues in the Management of Unruptured Intracranial Aneurysms Robert D. Brown, Jr., MD, MPH, FAAN
04:35 PM - 04:45 PM		Questions and Answers Robert D. Brown, Jr., MD, MPH, FAAN

Faculty Disclosures
Robert D. Brown, Jr., MD, MPH, FAAN	Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care.
Jeffrey L. Saver, MD, FAAN	Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.
Alejandro A. Rabinstein, MD, FAAN	Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainomix. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Rabinstein has received research support from Chiesi. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Ralph L. Sacco, MD, MS, FAHA	Dr. Sacco has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Sacco has received research support from NIH, NINDS, NCATS, NIMHD. The institution of Dr. Sacco has received research support from FL Department of Health. Dr. Sacco has received research support from University of Washington, Seattle. Dr. Sacco has received publishing royalties from a publication relating to health care.
Thomas G. Brott, MD, FAAN	Dr. Brott has nothing to disclose.
Cathy A. Sila, MD, FAAN	The institution of Dr. Sila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syntactx . Dr. Sila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Sila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca .
Harold P. Adams, Jr., MD, FAAN	The institution of Dr. Adams has received research support from NINDS.
Joseph P. Broderick, MD, FAAN	Dr. Broderick has received publishing royalties from a publication relating to health care.